July.18th-19th, 2024 Chengdu, China
CGT Asia Chengdu – The 6th Asia Cell & Gene Therapy Innovation Summit 2024
Sep. 26th-27th, 2024 Guangzhou, China
CGT Asia Guangzhou – The 7th Asia Cell & Gene Therapy Innovation Summit 2024

Buy tickets

Request agenda

Get floorplan

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Safety Evaluation, mRNA, NK, Macrophages, Stem Cell Therapy, iPSC, Allogeneic CAR-T, CAR-M, CAR-NK, Solid Tumors, Ophthalmology, Rare Diseases, Neurodegenerative Diseases, MicroRNA Drugs, In vitro and In vivo Delivery.

Commercialization and Innovative Drug Access to Hospitals, Clinically Oriented and Innovative Therapies, Stem Cell Therapy, Extracellular Vesicles Therapy, Cell Therapy, Gene Therapy, Rare Disease, Single-Cell Sequencing, Biomarkers, Immune Cell, TCR-T, CAR-NK, CRISPR/CAS9 Gene Editing, iPSC, PCR, High-Throughput Screening, Application Plans, Continuous Production Process, GMP, AAV, (Non-) Viral Vectors etc.

Topics Highlights

The 6th Asia Cell & Gene Therapy Innovation Summit 2024 (Chengdu)

Latest Progress of Stem Cell Therapy for Osteoarthritis and Therapeutic Mechanisms Based on Monkey Models
NK Cell Therapy Brings New Hope to Tumor Patients
Clinical Advances in rAAV Gene Therapy for Fabry Disease rAAV
Development of Innovative Class I Drugs for Neovascular AgeRelated Macular Degeneration (nAMD) Gene Therapy
Strategies for Nonclinical Study Evaluation of Cell and Gene Therapy Products
Optogenetic Technology - A Broad-Spectrum Gene Therapy for Sight Restoration
Progress and Developmental Insights on U niversal CAR-T Therapy
Constructing a Tumor Organoid Library to Facilitate Cell and GeneTherapy Drug Development
Nucleic Acid Drug Development Platform Based on Innovative RNA Vectors
Analysis of Current Judicial Practices and Regulatory Trends in the Cell Industry Commercialization Format
......

The 7th Asia Cell & Gene Therapy Innovation Summit 2024 (Guangzhou)

Top CDMO Fuels Productivity Gains, Cost Reductions and Accelerated New Drug Launches
Case Study: The Journey of TILs Therapies for Melanoma from R&D to Approval for Marketing
mRNA Technology Enables Regenerative Medicine Therapies to Treat Diseases Cause from Aging
Exploring Global Business Expansion in the CGT Industry from the Perspective of MNC Vision
Industry 4.0 and AloT in Cell Therapy Pharmaceuticals
Latest Clinical Data Sharing of "Super NK", a Gene-Editing Based iPSC-NK Therapy
CGT 2024 Related Latest Policies and Regulations Interpretation and Analysis and Approval Requirements
Recent Applications of CRISPR/Cas9 Gene Editing Technology
Recent Advances in the Treatment of Huntington's Chorea with RNAi Drugs (siRNA)
......